3658 results for «2013»
3658 results
Challenging scenarios in the pulmonary system - Part 2
23 May 2025 – From EuroPCR 2025
Delve into complex pulmonary interventions through cases highlighting pulmonary thrombectomy, intracavitary thrombus management, and challenges in simultaneous pulmonary embolism and ischemic stroke. This session emphasizes minimally invasive approaches and strategic decision-making in pulmonary vascular disease.
Coronary complications: stent loss
22 May 2025 – From EuroPCR 2025
Examine coronary stent loss complications and retrieval techniques in this session. Review innovative approaches such as retrieval of dislodged stents from unusual locations like the renal artery, and discussions on navigating stent-related struggles, including the mechanical journey and consequences of stent loss during PCI.
TMVIV - TMVIR and its challenges
23 May 2025 – From EuroPCR 2025
Explore the challenges and innovations in transcatheter mitral valve-in-valve and valve-in-ring procedures. This session presents alternative access routes, management of paraannular compromise, and complex cases involving ECMO support and unexpected outcomes, offering valuable insights into advanced mitral interventions.
Stent failure: don't guess, just see!
22 May 2025 – From EuroPCR 2025
Investigate causes and imaging-based solutions for stent failure in this session. Topics include management of refractory stent underexpansion using lithotripsy or stent ablation, OCT perspectives on iatrogenic aortic dissection during PCI for in-stent restenosis, and analyses of bioresorbable scaffold failure. Gain insights into complex stenting techniques...
When strange things happen, CTO and complications
23 May 2025 – From EuroPCR 2025
This session addresses complications and unexpected challenges encountered in chronic total occlusion (CTO) interventions. Learn from cases involving retrieval of stuck wires, coronary perforations, and strategies to manage complex and unusual procedural difficulties.
Challenging left main PCI in NSTEMI patients
22 May 2025 – From EuroPCR 2025
Address the complexities of left main PCI in NSTEMI patients with challenging clinical presentations. This session discusses management of complex left main bifurcation disease, early graft failure guided by imaging and physiology, revascularization strategies for coronary left main occlusion, PCI complications requiring CTO techniques, and acute...
Challenges and complications in coronary interventions
23 May 2025 – From EuroPCR 2025
Discuss real-world challenges and complications in coronary interventions including heavily calcified LAD PCI, cardiac crisis management, and rare intramural hematoma cases. The session emphasizes the importance of IVUS guidance and operator expertise in complex scenarios.
STEMI - What if a culprit lesion is not identifiable?
20 May 2025 – From EuroPCR 2025
Address challenging STEMI cases where culprit lesions are not immediately identifiable. This session emphasizes the utility of intravascular imaging in guiding decision-making and optimizing percutaneous interventions through illustrative cases involving left main stenosis, ambiguous culprit lesions, and etiological dilemmas in coronary occlusion.
Risk stratification of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...
Troubleshooting and management communication in LAA closure
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on troubleshooting and communication during left atrial appendage (LAA) closure procedures. Covering device migration management, transeptal puncture in high bleeding risk patients, scoliosis adaptations, and advanced catheter techniques, it emphasizes practical solutions for procedural complications.
How to build a tricuspid programme?
20 May 2025 – From EuroPCR 2025
Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...
Pushing boundaries in complex PCIs: unique DES technology for complex lesions and patients
21 May 2025 – From EuroPCR 2025
Explore cutting-edge strategies in complex PCI through four detailed clinical cases: a challenging left main bifurcation, a complex procedure using Guideliner Extension Catheters (GEC), an acute coronary syndrome intervention, and treatment of a patient with high bleeding and ischemic risks. This session demonstrates how thorough patient...
Clinical impact of mechanical circulatory support
22 May 2025 – From EuroPCR 2025
Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...
Is DCB a new valid option for coronary revascularisation?
22 May 2025 – From EuroPCR 2025
This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...
Coronary scaffolds: new developments and applications
21 May 2025 – From EuroPCR 2025
Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.
Challenging scenarios in patient with multivessel disease
20 May 2025 – From EuroPCR 2025
Explore challenging clinical scenarios in patients with multivessel coronary artery disease. This session presents complex cases such as coronary aneurysms, failed bypass grafts, limitations of intravascular lithotripsy, and rare pathologies like Takayasu’s arteritis, highlighting decision-making and advanced intervention strategies.
Mitral TEER in challenging scenarios - Part 2
21 May 2025 – From EuroPCR 2025
This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
